Login / Signup

Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases.

Ozlem AltayHong YangSerkan YıldırımCemil BayramIsmail BolatSena OnerOzlem Ozdemir TozluMehmet Enes ArslanAhmet HacimuftuogluSaeed ShoaieCheng ZhangJan BorénMathias UhlénHasan TurkezAdil Mardinglu
Published in: Biomedicines (2024)
Our findings suggest that the administration of both CMA1 and CMA2 markedly enhanced metabolic and behavioral outcomes, aligning with neuro-histological observations. These findings underscore the promise of CMA2 administration as an effective therapeutic strategy for enhancing metabolic parameters and cognitive function in AD and PD patients.
Keyphrases
  • newly diagnosed
  • type diabetes
  • prognostic factors
  • metabolic syndrome
  • deep learning
  • weight loss